懒惰人民
发表于 2025-3-23 10:30:22
http://reply.papertrans.cn/55/5427/542680/542680_11.png
广口瓶
发表于 2025-3-23 16:35:03
http://reply.papertrans.cn/55/5427/542680/542680_12.png
事与愿违
发表于 2025-3-23 20:25:10
http://reply.papertrans.cn/55/5427/542680/542680_13.png
疼死我了
发表于 2025-3-24 00:25:38
Peripheral Arterial Disease in Chronic Kidney Disease: Disease Burden, Outcomes, and Interventionalpatients with chronic kidney disease (CKD). PAD is particularly common in those with severe CKD, and early detection and effective treatment of PAD is indicated in those with CKD and concomitant PAD. Measurement of the ankle-brachial index is a simple, reliable, and noninvasive test to diagnose PAD
Ventricle
发表于 2025-3-24 03:03:22
Cardiovascular Impact of Atherosclerotic Renovascular Diseaseich activates the renin-angiotensin-aldosterone system and increases a variety of inflammatory and pro-fibrotic cytokines. This results in the development of hypertension and a decline in renal function. Unfortunately the finding of renal artery stenosis does not always imply the presence of renal i
Prologue
发表于 2025-3-24 08:23:50
Therapeutic Considerations with Revascularization in Chronic Kidney Disease: Radial Versus Femoral Atable settings. Recent evidence suggests potential nephroprotective benefits of the radial approach over the femoral route toward both short- and long-term kidney injury preventions. Acute kidney injury (AKI) after cardiac catheterization remains a major issue in hospitalized patients and is associa
持久
发表于 2025-3-24 10:59:22
Antiplatelet Agent Choice and Platelet Function Testing in CKD of the platelet COX-1 enzyme by aspirin and the P2Y.-ADP interaction by P2Y. receptor inhibitors is a major pharmacologic strategy to prevent acute as well as long-term thrombotic event occurrences following PCI. Clopidogrel, the most widely used P2Y. receptor inhibitor, is associated with wide res
骗子
发表于 2025-3-24 16:35:22
Choice of Stents and Clinical Outcomes in Patients with Chronic Kidney Diseases (ST) following percutaneous coronary intervention (PCI). However, patients with chronic kidney disease (CKD) are characterized by unique risk factors that ought to be considered when selecting a coronary stent. In addition to the systemic risk factors in patients with CKD, atherosclerotic lesions
Optimum
发表于 2025-3-24 22:20:37
Revascularization Strategies in Chronic Kidney Disease: Percutaneous Coronary Interventions Versus Cis associated with the development and progression of atherosclerotic cardiovascular disease. In addition to traditional cardiovascular risk factors such as hypertension, smoking, diabetes mellitus, and hyperlipidemia, patients with CKD also carry nontraditional risk factors such as increased vascul
BRIEF
发表于 2025-3-25 02:54:32
http://reply.papertrans.cn/55/5427/542680/542680_20.png